Dr. med. Ferdinand Knieling from the University Hospital Erlangen presents his group’s groundbreaking pilot study, published in Nature Communications. In this session, Dr. Knieling explores the role of biomarkers in assessing muscle degeneration in Pompe disease and demonstrates the potential of iThera’s optoacoustic imaging technology as a clinical diagnostic tool for neuromuscular diseases. The session features an in-depth discussion of the study results, followed by an engaging Q&A session.
